A 'fly­over' biotech launch­es in Texas with four Ron De­Pin­ho-found­ed com­pa­nies un­der its belt

In his 13 years at Gen­zyme, Michael Wyz­ga no­ticed some­thing about East Coast drug­mak­ers. Ex­ecs would of­ten jet from Boston or New York to San Fran­cis­co to find more as­sets, and com­plete­ly miss the work be­ing done in fly­over states, like Texas or Wis­con­sin.

“If it doesn’t come out of MGH or MIT or Har­vard, prob­a­bly not that in­ter­est­ing,” he said of the mind­set.

Now, he and some well-known in­dus­try play­ers are look­ing to change that, and they’ve reeled in just over $38 mil­lion to do it.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER